← Back
Data updated: Mar 29, 2026
HERAN
OncologyNeurology
Generics
HERAN is a generic drug manufacturer focused on Oncology, Neurology.
1983
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 52%
0 drugs Phase 2: 2 Phase 1: 7
Neurology 48%
0 drugs Phase 2: 1 Phase 1: 8
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 1983-10-03
- Latest
- 1983-10-03
- Applications
- 1